Antioxidant Activity of Sprouts Extracts Is Correlated with Their Anti-Obesity and Anti-Inflammatory Effects in High-Fat Diet-Fed Mice

Table 3

Body weight gain, diet intake, and visceral adipose tissue weight of mice.

	LFC (n = 7)	HFC (n = 8)	LY (n = 8)	CS-L (n = 8)	CS-H (n = 8)	OB-L (n = 8)	OB-H (n = 8)
Initial body weight (g)	21.5 ± 0.9^ns	21.6 ± 0.5	21.8 ± 0.8	21.6 ± 0.9	21.6 ± 0.8	21.7 ± 0.5	21.5 ± 0.6
Body weight gain (g)	8.1 ± 1.5^c2)	18.4 ± 2.7^a	13.1 ± 2.8^b	13.3 ± 1.9^b	10.4 ± 1.7^c	10.2 ± 2.3^c	9.8 ± 2.7^c
Diet intake (g)	270.9 ± 5.0^a	237.0 ± 1.2^b	237.2 ± 13.5^b	249.3 ± 18.4^b	235.5 ± 14.4^b	238.1 ± 24.8^b	235.6 ± 14.2^b
Energy intake (kcal)	1034.7 ± 19.3^b	1114.1 ± 5.6^a	1114.7 ± 63.3^a	1171.7 ± 86.5^a	1107.0 ± 67.9^ab	1119.1 ± 116.3^a	1107.4 ± 66.7^ab
Food efficient ratio (%g/g)^1)	2.98 ± 0.55^e	7.77 ± 1.10^a	5.53 ± 1.11^b	5.34 ± 0.74^bc	4.46 ± 0.85^cd	4.24 ± 0.58^d	4.16 ± 1.06^d
Epididymal fat (g)	0.73 ± 0.25^d	2.25 ± 0.30^a	1.62 ± 0.25^b	1.38 ± 0.42^bc	1.11 ± 0.42^c	1.24 ± 0.30^c	1.10 ± 0.21^c
Perirenal fat (g)	0.25 ± 0.08^d	0.96 ± 0.14^a	0.77 ± 0.17^b	0.58 ± 0.23^c	0.49 ± 0.24^c	0.56 ± 0.11^c	0.52 ± 0.13^c
Liver weight (g)	1.39 ± 0.21^a	1.31 ± 0.24^ab	1.15 ± 0.10^bc	1.23 ± 0.17^abc	1.16 ± 0.15^bc	1.09 ± 0.14^c	1.09 ± 0.12^c

LFC: low-fat diet (LFD) control, HFC: high-fat diet (HFD) control, LY : HFD + oral treatment with lycopene beadlets at 50 mg/kg body weight (BW) containing 5% tomato lycopene (positive control), CS-L : HFD + oral treatment with 50% ethanol extract of Cedrela sinensis (CS) at 50 mg/kg BW, CS-H : HFD + oral treatment with CS extract 100 mg/kg BW, OB-L : HFD + oral treatment with 50% ethanol extract of Oenothera biennis L. (OB) at 50 mg/kg BW, OB-H : HFD + oral treatment with OB extract 100 mg/kg BW. Values are mean ± SD. ns: not significant. (1) Food efficient ratio = (body weight gain (g)/food intake (g)) x 100, (2) means sharing the same alphabet in superscripts are not significantly different within a row at as determined by ANOVA and Duncan’s multiple range test.